In these studies, cells with a CD11b+Gr1+Ly6G+LY6Cmed/low phenotype have been shown to expand over the course of cancer progression, and functional assays to assess their immunosuppressive properties have not always been performed (79, 80).. This evidence concerns the gene ITGAM and cancer.